(Q67733232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

11 November 2022

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

11 November 2022

author name string

P. P. De Jaegere

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732354

11 November 2022

A. A. Arnold

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732354

11 November 2022

A. H. Balk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732354

11 November 2022

M. L. Simoons

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732354

11 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:073510979290480B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

https://api.elsevier.com/content/article/PII:073510979290480B?httpAccept=text/plain

11 November 2022

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Journal of the American College of Cardiology

11 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

289-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

11 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

11 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

11 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

11 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

11 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction

11 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Plasminogen Activator Italian Multicenter Study (PAIMS): comparison of intravenous recombinant single-chain human tissue-type plasminogen activator (rt-PA) with intravenous streptokinase in acute myocardial infarction

11 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

11 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

A case-cohort design for epidemiologic cohort studies and disease prevention trials

11 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

11 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator

11 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study

11 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin

11 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

11 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

11 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study

11 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction

11 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

11 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

11 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

11 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

11 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Intracerebral hemorrhage revisited

11 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Update from the Thrombolysis in Myocardial Infarction Trial

11 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Intracerebral hemorrhage: non-hypertensive causes

11 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Cerebral amyloid angiopathy. A critical review

11 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

11 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase

11 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage

11 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator?

11 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0735-1097(92)90480-B

11 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732354%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference